URGN FY 2019 Earnings — UroGen Pharma Ltd. Revenue & Financial Results | Market Cap Arena

URGNUroGen Pharma Ltd.

$918M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$18,000-98.4% YoY

Gross Profit

$18,000100.0% margin

Operating Income

-$109M-608211.1% margin

Net Income

-$105M-584144.4% margin

EPS (Diluted)

$-4.90

Cash Flow

Operating Cash Flow

-$71M

Free Cash Flow

-$71M

Stock-Based Comp.

$30M

Balance Sheet

Total Assets

$202M

Total Liabilities

$22M

Stockholders' Equity

$180M

Cash & Equivalents

$50M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18,000	$1M	-98.4%
Gross Profit	$18,000	-$675,000	+102.7%
Operating Income	-$109M	-$77M	-41.8%
Net Income	-$105M	-$76M	-39.0%